Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Monthly Archives: March 2017
Kite’s CAR T-Cell Therapy Success – The Scientist
Posted: March 1, 2017 at 11:41 pm
The Scientist | Kite's CAR T-Cell Therapy Success The Scientist Last year, both Juno Therapeutics and Kite Pharma announced that a small number of patients had died in their respective CAR T-cell therapy trials. Juno's trial was halted, but Kite's carried on. The Kite study enrolled 77 patients with advanced ... CAR T-cell therapy turns blood cells into cancer fighters Gene therapy "seems extraordinary" at fighting blood cancer in study, experts say Terminal cancer patients in complete remission after one gene therapy treatment |
Read more from the original source:
Kite's CAR T-Cell Therapy Success - The Scientist
Posted in Cell Therapy
Comments Off on Kite’s CAR T-Cell Therapy Success – The Scientist
Stem cell treatment changed the life of one guest at Trump’s speech … – CNN
Posted: March 1, 2017 at 11:41 pm
She credits an experimental stem cell treatment with giving her new hope for her health and her future -- a newfound hope that also caught attention of Republican Rep. Pete Olson.
"She is the face of the 21st Century Cures Act because of what she's gone through in her life," he said Tuesday.
"It became pretty clear to me that ... I (have) got to tell her story," he said. "That's why she's here: She's awesome."
Immediately after the House vote, Hughes said, Olson called her at home to invite her to be his guest of honor.
"I still cannot believe I will be in the same room as our President and lawmakers," she said before attending Trump's speech.
It took Crowley's father, John, to launch the New Jersey biotechnology company Amicus Therapeutics to identify a drug treatment that would save her life, Trump said.
"If we slash the restraints, not just at the FDA but across our Government, then we will be blessed with far more miracles like Megan," he said. "In fact, our children will grow up in a Nation of miracles."
Hughes spent most of her adolescence hospitalized, as she became so sick that she could barely walk and suffered immense pain. Her body was evaluated, treated and studied at the National Institutes of Health in collaboration with her doctors from the University of Texas Health Science Center at Houston.
Yet relief came in 2014, when Hughes received a high-dose adult stem cell treatment that was not approved in the United States.
For the procedure, Hughes had her own healthy stem cells cultured at the FDA-registered biotechnology company Celltex Therapeutics in Houston. Then she traveled to Cancun, Mexico, to have the cells infused back into her body.
Each infusion involved about 200 million stem cells, and Hughes received some 22 infusions over almost two years. The cells could help normalize her immune system, which was overactive due to her autoimmune disease.
Before the stem cell therapy, Hughes said, she was taking 23 medications a day. Now, she is on eight medications at lower doses.
"If not for the help of high-dose autologous mesenchymal stem cell therapy, I would not be here today," Hughes said at the hearing.
"I was running out of time, but I was willing to put my life at risk to get on an airplane. My quality of life had become so dismal, even one small improvement from my own stem cells would have been enough for me," she said in her speech. "What happened in the days, weeks and years following my first infusion has changed my outlook. It's hard to believe, in my sick body, I had a wealth of healthy adult stem cells with the ability to so significantly improve my quality of life."
"My hope is that our new President will spend time looking at how to help all Americans have access to new therapies like the one I had," she said.
Here is the original post:
Stem cell treatment changed the life of one guest at Trump's speech ... - CNN
Posted in Cell Therapy
Comments Off on Stem cell treatment changed the life of one guest at Trump’s speech … – CNN
Stem Cell Therapy Market Worth 145.8 Million USD by 2021 – Yahoo Finance
Posted: March 1, 2017 at 11:41 pm
PUNE, India, February 28, 2017 /PRNewswire/ --
According to a new market research report "Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Surgery, and aGVHD), Cell Source (Adipose tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs) - Global Forecasts to 2021" published by MarketsandMarkets, the market is expected to reach USD 145.8 Million by 2021, growing at a CAGR of 11.0%.
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 60 market data Tables and 37 Figures spread through 120 Pages and in-depth TOC on "Stem Cell Therapy Market"
http://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html
Early buyers will receive 10% customization on this report.
The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW) for the forecast period of 2016 to 2021. Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global Stem Cell Therapy Market.
On the basis of type, the global Stem Cell Therapy Market is divided into two major categories, namely, allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic stem cell therapy segment is expected to command the largest share in the global Stem Cell Therapy Market in 2016. This large share can primarily be attributed to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, and growing number of clinical trials related to allogeneic stem cell therapies.
Inquiry Details: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=48
On the basis of therapeutic application, the global Stem Cell Therapy Market is segmented into musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and other applications. The musculoskeletal disorders segment is expected to command the largest share of the global Stem Cell Therapy Market in 2016. This large share can be attributed to the rising availability of stem cell-based products for the treatment of musculoskeletal disorders, high prevalence of musculoskeletal disorders and bone & joint diseases, and growing patient preference for effective & early treatment strategies.
North America is expected to be the largest regional segment in the global Stem Cell Therapy Market in 2016, followed by Asia-Pacific. In addition, the North American Stem Cell Therapy Market is expected to be the fastest growing region during the forecast period. Factors such as growing awareness related to the therapeutic potency of stem cells, increasing number of clinical trials for stem cell-based products, and increasing public-private funding & research grants are driving the growth of this market.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=48
As of 2015, Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) are some of the key players operating in the global Stem Cell Therapy Market.
Browse Related Reports:
Stem Cell Assay Market by Type (Viability, Differentiation, Cell Identification), Kit (Mesenchymal, IPSCS, Hematopoietic), Product (Flow Cytometer, Detection Kit), Application (Regenerative Medicines, Drug Development), End User - Forecast to 2021
http://www.marketsandmarkets.com/Market-Reports/stem-cell-assay-market-47610330.html
Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021
Read More
http://www.marketsandmarkets.com/Market-Reports/stem-cell-banking-market-220680183.html
About MarketsandMarkets:
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact: Mr. Rohan MarketsandMarkets 701 Pike Street Suite 2175, Seattle, WA 98101, United States 1-888-600-6441 Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @http://www.linkedin.com/company/marketsandmarkets
Original post:
Stem Cell Therapy Market Worth 145.8 Million USD by 2021 - Yahoo Finance
Posted in Cell Therapy
Comments Off on Stem Cell Therapy Market Worth 145.8 Million USD by 2021 – Yahoo Finance
Fasting Diet Reverses Diabetes in Mice – Voice of America
Posted: March 1, 2017 at 11:40 pm
A diet that mimics fasting temporarily put mice in a starvation state, reversing diabetes in the animals, according to a new study. The diet was also shown to reduce the risk factors in people with pre-diabetes
Research by investigators at the University of Southern California showed the special, fasting-mimicking diet triggers the development of insulin-producing cells in mice with diabetes. The study was published in the journal Cell.
In humans, an earlier study of the diet reduced the risk factors of diabetes, such as elevated blood sugar, in people who were headed toward development of the disease. An article on the diet in humans appeared in Science Translational Medicine.
In both Type 1 diabetes and in the later stages of Type 2 diabetes, the beta cells of the pancreas are destroyed. But the authors said the diet appears to "reboot" the body, switching on genes that trigger the release of stem cells, master cells responsible for organ development.
More than fasting required
However, fasting alone is not the key to restoring insulin levels. Scientists said refeeding after the brief starvation diet, with specially calibrated nutrients, is critical to kickstarting the production of new beta cells.
FILE - A woman fills a syringe as she prepares to give herself an injection of insulin.
The process of stem cell activation is the same as seen in embryos to stimulate organ growth, according to gerontology professor Valter Longo, the director of USC's Longevity Institute and senior author of both studies. He said the fasting-mimicking diet can be used to reprogram cells without any genetic alterations.
"So basically the system is using some of the same program that we use during embryonic and fetal development to regenerate the pancreas once the food comes back around," he said. "And that's the trick. It's not so much the starvation. It's really the combination of the starvation and the refeeding." And, he stressed, "the refeeding's got to be a high-nourishment one."
Study participants put on the high-fat, low-calorie, low-protein diet consumed between 800 and 1,100 calories daily for five days in a row each month for three months. After each fast, they were refed with nutrient-rich foods.
Researchers found fasting triggered the production of a protein called Ngn3, which generated new, healthy beta cells that secreted insulin. They saw production of insulin in a dish in pancreatic cells extracted from mice and from healthy human donors and patients with both types of diabetes.
Scientists found the diet replaced damaged insulin-producing cells with new functioning ones in mice placed on the diet for four days.
Heart disease, cancer risks
The investigators have also amassed evidence that the fasting-mimicking diet reduces the risk of age-related diseases, including heart disease and cancer. It may also hold benefits for people with multiple sclerosis, said researchers.
FILE - A woman who suffers from diabetes is seen walking on a treadmill as part of an exercise program to help control the disease.
But Longo said people with diabetes should not try the diet at home yet because it can drop blood sugar to perilously low levels if they don't know what they are doing. "We warn people that, particularly [for people with] Type 1 or patients that inject themselves with insulin, it can be very risky or even lethal," Longo cautioned.
He said investigators were poised to begin larger human clinical trials of the fasting-mimicking diet in the next six months.
Continue reading here:
Fasting Diet Reverses Diabetes in Mice - Voice of America
Posted in Diabetes
Comments Off on Fasting Diet Reverses Diabetes in Mice – Voice of America
Before diabetes strikes – The New Indian Express
Posted: March 1, 2017 at 11:40 pm
BENGALURU:There is growing burden of diabetes in India. The Indian Council of Medical Research (ICMR) estimated that the country already had around 65.1 million diabetes patients.
As per a survey by National Center for Biotechnology Information in Bangalore, the prevalence of diabetes was 12.33 per cent and of pre-diabetes was 11.57 per cent of the total population.
Increasing age, being overweight and obese, sedentary lifestyle, unhealthy and untimely dietary habits have well proven association with prevalence of diabetesPre-diabetes is a condition that predates diabetes mellitus. In pre-diabetes stage the levels of blood glucose are higher than normal but, remain below diabetic range.
The condition is very common among Asians, especially Indians and data from different sources across the countries showed that nearly 20 per cent of urban Indians are prone to it. Certain lifestyle changes taken in pre-diabetes stage can prevent diabetes.
Symptoms
Diabetic patients with uncontrolled sugars usually suffer from increased frequency of urination, weight loss and extreme fatigue, but in pre-diabetes stage, the patient normally does not have any symptoms. A regular monitoring referred to as screening test would be the only way to diagnose the condition.
Causes and Risk factors
Insulin is an essential element to transport glucose that the body produces to convert into energy. In pre-diabetes, the body is not able to produce enough insulin or is not able to function efficiently, also called insulin resistance leading to a higher-than-normal blood sugar level and possibly pre-diabetes. Prevention and treatment
Pre-diabetes is the warning sign before it progresses to become type 2 diabetes. It is complex, multi-factorial, hugely influenced by genetic predisposition, lifestyle factors and excessive calorie intake. Eating well, eating healthy and regular exercise helps prevent progression of pre-diabetic patients to Type 2 diabetes. It is observed that consumption of vegetables had a significant connection with diabetes.
People who consumed more than two servings of vegetable had lesser prevalence of diabetes. Many studies have shown that use of consuming high water soluble fibers present in vegetable and fruits and polyunsaturated fat in fish, help in preventing diabetes.
Similarly, people at risk of and also those identified with pre-diabetes would benefit from lifestyle a change that includes weight loss and exercise for at least 30 minutes every day. This can improve insulin resistance and can lower elevated blood sugar levels diabetes.
The author is a Consultant Diabetologist & Endocrinologist, Fortis Hospital, Bannerghatta Road
See the rest here:
Before diabetes strikes - The New Indian Express
Posted in Diabetes
Comments Off on Before diabetes strikes – The New Indian Express
Can fast and furious exercise prevent diabetes? – Medical Xpress
Posted: March 1, 2017 at 11:40 pm
March 1, 2017 Patients with fatty liver disease may need a more intense dose of exercise. Credit: University of Queensland
Short bursts of high-intensity exercise could help people with non-alcoholic fatty liver disease reduce their risk of type 2 diabetes.
A trial led by University of Queensland School of Human Movement and Nutrition Sciences researcher Dr Shelley Keating will investigate if high intensity interval training (HIIT) can improve insulin sensitivity, fitness and other cardiovascular disease risk factors.
"Other than weight loss, there is no accepted therapy for improving non-alcoholic steatohepatitis (NASH) a type of fatty liver disease which is strongly linked to type 2 diabetes and cardiovascular disease," Dr Keating said.
"We have recently demonstrated that exercise therapy reduces liver fat in adults with obesity, but patients with NASH may need a more intense 'dose' of exercise.
"We hope to establish that high-intensity exercise is a safe, feasible and effective therapy for improving insulin resistance and other cardio-metabolic risk factors.
"Given that up to one-third of Australians have non-alcoholic fatty liver disease, and the subsequent rate of progression to NASH is around 30 per cent, the impact on the community is significant."
Study participants will complete 12 weeks of HIIT supervised by an accredited exercise physiologist at UQ's St Lucia campus in Brisbane, followed by 12 weeks of HIIT at home.
"The sessions will involve short, intense bursts of exercise around four minutes on a treadmill or exercise bike at near maximum capacity - interspersed with more moderate exercise," Dr Keating said.
"Health measures including insulin sensitivity, body composition, vascular function, and fitness will be assessed before and after the supervised and home-based phases.
"It is very important that individuals can continue on with HIIT in the long-term so that the health benefits can be sustained," Dr Keating said.
People with biopsy-proven NASH, or their clinicians, should contact Dr Keating (see below) for details on how to take part in the trial.
Explore further: Diet and exercise can improve kidney function in patients with fatty liver disease
Non-alcoholic steatohepatitis (NASH) is a potentially serious liver condition characterized by excess fat in the liver associated with inflammation and scarring. NASH may progress to cirrhosis of the liver and liver cancer, ...
(Medical Xpress)High-intensity interval training (HIIT) is touted as the fastest way to get lean, but according to ground-breaking new research from the University of Sydney's Charles Perkins Centre, only endurance exercise ...
A University of Queensland researcher is trialling a 12-minute exercise plan that aims to fight type 2 diabetes in a flash.
Listening to music may make it easier for people to adopt short duration exercise regimens that could help them stay in shape, according to researchers at UBC's Okanagan campus.
Understanding how exercise affects language learning could help patients with brain conditions such as stroke, Alzheimer's and Parkinson's disease.
Time-poor people who do fewer repetitions during high-intensity interval training (HIIT) workouts may get better fitness benefits than those who complete more, according to a University of Stirling analysis.
Short bursts of high-intensity exercise could help people with non-alcoholic fatty liver disease reduce their risk of type 2 diabetes.
A diet designed to imitate the effects of fasting appears to reverse diabetes by reprogramming cells, a new USC-led study shows.
(Medical Xpress)A team of researchers with members from several institutions in Germany and one in the U.K. has discovered what might be a way to tell if a newborn child is likely to develop type 1 diabetes as they grow ...
People with diabetes are at high risk of developing heart disease. Despite knowing this, scientists have struggled to trace the specific biology behind that risk or find ways to intervene. Now, UNC School of Medicine researchers ...
A long-term study by Monash University researchers - the first of its kind - has found that gastric band surgery has significant benefits for moderately overweight people with type 2 diabetes. Previous studies have focused ...
Blood sugar triggers the secretion of insulin from cells in the pancreas, a process that is impaired in diabetes. A team of Yale researchers have identified a mechanism at the membranes of these pancreatic cells that controls ...
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Original post:
Can fast and furious exercise prevent diabetes? - Medical Xpress
Posted in Diabetes
Comments Off on Can fast and furious exercise prevent diabetes? – Medical Xpress
